Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 5/20 | 0.64 |
| ▸ | CCKBR | P32239 | 9/20 | 0.59 |
| ▸ | CCKAR | P32238 | 2/20 | 0.59 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.59 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30037155 | 0.98 | IL23R (0.62) | IL23RCCKBRCCKARKEAP1PTH1R | |
| SCHEMBL29389186 | 0.98 | IL23R (0.62) | IL23RCCKBRCCKARKEAP1PTH1R | |
| SCHEMBL29410268 | 0.98 | IL23R (0.62) | IL23RCCKBRCCKARKEAP1PTH1R | |
| SCHEMBL29534029 | 0.97 | IL23R (0.61) | IL23RCCKBRCCKARKEAP1PTH1R | |
| SCHEMBL30037407 | 0.97 | IL23R (0.61) | IL23RCCKBRCCKARKEAP1PTH1R | |
| SCHEMBL29533546 | 0.93 | C5AR1 (0.63) | IL23RCCKBRKEAP1PTH1R | |
| SCHEMBL29533850 | 0.93 | C5AR1 (0.63) | IL23RCCKBRKEAP1PTH1R | |
| SCHEMBL29534240 | 0.93 | C5AR1 (0.63) | IL23RCCKBRKEAP1PTH1R | |
| SCHEMBL29533859 | 0.93 | C5AR1 (0.63) | IL23RCCKBRKEAP1PTH1R | |
| SCHEMBL29533287 | 0.92 | CCKBR (0.60) | IL23RCCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11426400-B2 | Methods of increasing satellite cell proliferation with vorinostat or bosutinib | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-08-30 | — | — | US | disclosed |
| US-20220054499-A1 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2022-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220054499-A1 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | MKI67, MYLK2, MYH2 | IL23R 3786/4885CCKBR 1601/4885CCKAR 1370/4885 |
| US-11426400-B2 | Methods of increasing satellite cell proliferation with vorinostat or bosutinib | MKI67, CDK4, CDKN1A | IL23R 2802/4885CCKBR 2397/4885CCKAR 2734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.